HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Red blood cell alloantibodies and liver transplantation in Chinese patients.

Abstract
Red blood cell (RBC) alloantibodies are present in up to 14% of white recipients of liver transplants and can cause severe delayed hemolysis. A retrospective survey showed 17 cases (8.8%) of RBC alloantibodies in 192 consecutive Chinese recipients of liver transplants, compared with a 3.7% background hospital incidence. The spectrum of RBC alloantibodies was different from that in white recipients, with no anti-D or anti-K antibodies but with a significant incidence of anti-Mi (29%) antibodies. There was significantly increased transfusion in RBC alloantibody positive cases. Delayed hemolysis also resulted in higher day-7 bilirubin levels. A total of 7 to 86 antigen-positive units were issued in five RBC alloantibody cases, including three early deaths. Seven cases in the RBC alloantibody negative group, but none in the positive group, were salvaged by regraft. Blood banks servicing transplant centers should be aware of ethnic patterns in RBC alloantibodies. Delayed hemolysis may jeopardize patient survival as a result of difficult postoperative stabilization, especially in cases requiring massive transfusion.
AuthorsW Y Au, C L Liu, C M Lo, S T Fan, M F Lam, C K Lam
JournalTransplantation (Transplantation) Vol. 75 Issue 11 Pg. 1904-6 (Jun 15 2003) ISSN: 0041-1337 [Print] United States
PMID12811254 (Publication Type: Journal Article)
Chemical References
  • ABO Blood-Group System
  • Isoantibodies
Topics
  • ABO Blood-Group System (immunology)
  • Adult
  • Aged
  • Asian People
  • Erythrocytes (immunology)
  • Female
  • Hemolysis (immunology)
  • Humans
  • Isoantibodies (blood)
  • Jaundice (ethnology, immunology, mortality)
  • Liver Failure (ethnology, immunology, surgery)
  • Liver Transplantation (ethnology, immunology, mortality)
  • Male
  • Middle Aged
  • Postoperative Complications (immunology, mortality)
  • White People

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: